We showed that FOXQ1 expression could cause activity changes in various cancer-related pathways in 12 different tumor types, such as bladder urothelial carcinoma, prostate adenocarcinoma, skin cutaneous melanoma, and brain lower-grade glioma. This evidence concerns the gene FOXQ1 and cancer.